Author:
Lu Yingjuan,Leamon Christopher P.
Reference96 articles.
1. Adcock IM (2007) HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 150:829–831
2. Antoni C, Kalden JR (1999) Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis. Clin Exp Rheumatol 17:S73–S77
3. Assi K, Pillai R, Gomez-Munoz A et al (2006) The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis. Immunology 118:112–121
4. Atzeni F, Doria A, Carrabba M et al (2007) Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmun Rev 6:529–536
5. Barnette MS, Christensen SB, Essayan DM et al (1998) SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. J Pharmacol Exp Ther 284:420–426
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献